Progressive Care Inc.

CIK:0001402945|SEC Filings
v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenues, net $ 13,477 $ 11,556 $ 28,105 $ 22,948
Costs of revenue 8,782 7,997 19,405 16,242
Gross profit 4,695 3,559 8,700 6,706
Operating expenses        
Salaries and wages 2,166 1,701 4,282 3,300
Professional fees 384 274 862 1,048
Depreciation and amortization 757 72 1,533 137
Selling, general, and administrative 895 888 1,795 1,583
Impairment loss 9,792 [1] 0 9,924 [1] 0
Total operating expenses 13,994 2,935 18,396 6,068
(Loss) income from operations (9,299) 624 (9,696) 638
Other income (expense):        
Debt conversion expense 0 (5,206) 0 (5,206)
Gain on sale or disposal of property and equipment 0 3 1 3
Interest income 40 7 80 12
Interest expense (17) (65) (33) (214)
Total other income (expense) 23 (5,261) 48 (5,405)
Loss before income taxes (9,276) (4,637) (9,648) (4,767)
Provision for income taxes 0 0 0 0
Net loss attributable to common shareholders $ (9,276) $ (4,637) $ (9,648) $ (4,767)
Basic and diluted weighted average loss per common share (in dollars per share) $ (1.49) $ (1.05) $ (1.55) $ (1.22)
Weighted average number of common shares outstanding during the period – basic and diluted (in shares) 6,241 4,427 6,240 3,896
Product [Member]        
Revenues, net $ 10,518 $ 9,399 $ 21,773 $ 19,193
Costs of revenue 8,719 7,937 19,279 16,132
Service [Member]        
Revenues, net 2,959 2,157 6,332 3,755
Costs of revenue $ 63 $ 60 $ 126 $ 110
[1] Pharmacy Operations impairment loss during the six months ended June 30, 2024 was related to the write-down of a right-of-use asset as a result of taking the leased equipment out of service and not returning to service in the future.